|
14 Mar 2025 |
Dalmia Bharat
|
Consensus Share Price Target
|
1607.10 |
1912.17 |
- |
18.98 |
hold
|
|
|
|
|
04 Mar 2025
|
Dalmia Bharat
|
Axis Direct
|
1607.10
|
2180.00
|
1699.25
(-5.42%)
|
35.65 |
Buy
|
|
|
We maintain our BUY rating on the stock
|
|
28 Jan 2025
|
Dalmia Bharat
|
Geojit BNP Paribas
|
1607.10
|
2060.00
|
1813.20
(-11.37%)
|
28.18 |
Buy
|
|
|
|
|
23 Jan 2025
|
Dalmia Bharat
|
Axis Direct
|
1607.10
|
2000.00
|
1828.35
(-12.10%)
|
24.45 |
Buy
|
|
|
We maintain our BUY recommendation on the stock
|
|
22 Jan 2025
|
Dalmia Bharat
|
Motilal Oswal
|
1607.10
|
2100.00
|
1799.05
(-10.67%)
|
30.67 |
Buy
|
|
|
Dalmia Bharat (DALBHARA)’s 3QFY25 EBITDA declined 34% YoY to INR5.1b (11% miss due to lower-than-estimated volume and higher variable cost/t). EBITDA/t was down 33% YoY to INR767 (est. INR800).
|
|
12 Dec 2024
|
Dalmia Bharat
|
BOB Capital Markets Ltd.
|
1607.10
|
1773.00
|
1935.25
(-16.96%)
|
Target met |
Sell
|
|
|
DALBHARA's presence in East and South India may be hit by excess supply; we factor in 1% price hikes in FY26/FY27 after a dent in FY25
|
|
25 Nov 2024
|
Dalmia Bharat
|
Geojit BNP Paribas
|
1607.10
|
2080.00
|
1826.80
(-12.03%)
|
29.43 |
Buy
|
|
|
|
|
22 Oct 2024
|
Dalmia Bharat
|
BOB Capital Markets Ltd.
|
1607.10
|
1816.00
|
1804.45
(-10.94%)
|
Target met |
Hold
|
|
|
Revenue declined by 2%/15% YoY/QoQ to ~Rs 31bn in Q2FY25 as focus returned to volume growth over guarding against declining realisations
|
|
22 Oct 2024
|
Dalmia Bharat
|
Axis Direct
|
1607.10
|
2040.00
|
1804.45
(-10.94%)
|
26.94 |
Buy
|
|
|
We maintain our BUY rating on the stock with a TP of Rs 2040/share, implying an upside of 11% from the CMP.
|
|
21 Oct 2024
|
Dalmia Bharat
|
Sharekhan
|
1607.10
|
2200.00
|
1830.80
(-12.22%)
|
36.89 |
Buy
|
|
|
Management has reduced its volume growth guidance for FY2025 to 9% y-o-y from 12% y-o-y, anticipating lower industry growth rate, while it continues to eye volume growth of 1.5x that of industry growth.
|
|
21 Oct 2024
|
Dalmia Bharat
|
Motilal Oswal
|
1607.10
|
2250.00
|
1830.80
(-12.22%)
|
40.00 |
Buy
|
|
|
Dalmia Bharat (DALBHARA)’s 2QFY25 performance was weak as expected as its EBITDA declined 26% YoY to INR4.3b (5% miss) and EBITDA/t was down 32% YoY to INR650 (est. INR700).
|
|
21 Oct 2024
|
Dalmia Bharat
|
Prabhudas Lilladhar
|
1607.10
|
2073.00
|
1830.80
(-12.22%)
|
28.99 |
Accumulate
|
|
|
|
|
22 Jul 2024
|
Dalmia Bharat
|
Axis Direct
|
1607.10
|
2120.00
|
1771.15
(-9.26%)
|
31.91 |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
20 Jul 2024
|
Dalmia Bharat
|
Prabhudas Lilladhar
|
1607.10
|
2067.00
|
1818.70
(-11.63%)
|
28.62 |
Accumulate
|
|
|
|
|
19 Jul 2024
|
Dalmia Bharat
|
Sharekhan
|
1607.10
|
2250.00
|
1818.70
(-11.63%)
|
40.00 |
Buy
|
|
|
For Q1FY2025, Dalmia Bharat Limited’s (Dalmia) consolidated revenue came in line with our estimate at Rs. 3,621 crore (flat y-o-y), led by 6% y-o-y volume growth
|
|
19 Jul 2024
|
Dalmia Bharat
|
Emkay
|
1607.10
|
1800.00
|
1818.70
(-11.63%)
|
Target met |
Sell
|
|
|
We downgrade Dalmia Bharat to REDUCE from Buy owing to limited growth catalysts due to uncertainty over the Jaypee deal—as admitted to the NCLT by lenders.
|
|
20 Jun 2024
|
Dalmia Bharat
|
Axis Direct
|
1607.10
|
2140.00
|
1862.40
(-13.71%)
|
33.16 |
Buy
|
|
|
We values the company at 12x FY26E EV/EBITDA to arrive at a TP of Rs 2,140/share, implying an upside potential of 15% from the CMP. We maintain our BUY rating on the stock.
|
|
14 May 2024
|
Dalmia Bharat
|
Geojit BNP Paribas
|
1607.10
|
2094.00
|
1757.75
(-8.57%)
|
30.30 |
Buy
|
|
|
|
|
26 Apr 2024
|
Dalmia Bharat
|
BOB Capital Markets Ltd.
|
1607.10
|
2346.00
|
1799.75
(-10.70%)
|
45.98 |
Buy
|
|
|
Q4 revenue grew at a steady 10% YoY supported by ~19% volume growth while realisations weakened 7% YoY/QoQ
|
|
26 Apr 2024
|
Dalmia Bharat
|
Axis Direct
|
1607.10
|
2050.00
|
1799.75
(-10.70%)
|
27.56 |
Buy
|
|
|
Recommendation: We maintain our BUY recommendation on the stock.
|
|
25 Apr 2024
|
Dalmia Bharat
|
Emkay
|
1607.10
|
2200.00
|
1806.45
(-11.04%)
|
36.89 |
Buy
|
|
|
For Q4FY24, Dalmia Bharat (Dalmia) reported weak performance with EBITDA declining 8% YoY/16% QoQ to Rs6.5bn (est: Rs8bn).
|